| Product Name | MF | CAS | Details |
|---|
| piCRAC-1 | C17H10F6N4 | 2418049-54-2 | Details |
| 4-Piperidinecarboxamide | C16H15Cl2N3O2S | 519034-65-2 | Details |
| COX-2/5-LOX-IN-1 | C14H10ClN3O4S2 | 2410384-50-6 | Details |
| CXCR4 antagonist 9 | C21H27FN6 | 2304750-83-0 | Details |
| hCAI/II-IN-4 | C15H15N3O5S2 | 2480284-01-1 | Details |
| 11β-HSD1-IN-6 | C21H19ClN4O | 1303515-33-4 | Details |
| VPC-13789 | C21H16F3N3O | 2761146-51-2 | Details |
| Antitumor agent-53 | C24H18FN3O | 2757145-67-6 | Details |
| AM-1488 | C19H17N3O4S | 2079895-60-4 | Details |
| TYK2-IN-11 | C18H17N5O3S | 2757009-40-6 | Details |
| DNA-PK-IN-2 | C20H23N5O3 | 2665720-22-7 | Details |
| MAT2A-IN-7 | C17H13ClF3N3O2 | 2756458-77-0 | Details |
| FGFR-IN-3 | C18H27F2N5O2 | 2488762-63-4 | Details |
| SUN13837 | C21H29N5O2 | 1080650-67-4 | Details |
| ATP synthase inhibitor 2 | C21H22N2O3S | 2814540-76-4 | Details |
| EGFR-IN-52 | C19H18N4O3S | 454436-75-0 | Details |
| Antitumor agent-38 | C22H24N2O4 | 2744193-34-6 | Details |
| Myt1-IN-2 | C18H16N6O2S | 2719748-43-1 | Details |
| IMMH001 | C23H28N2O3 | 1418093-75-0 | Details |
| SARS-CoV-2-IN-20 | C24H30N2O2 | 1260244-33-4 | Details |
| SK3 Channel-IN-1 | C25H49NO | 2396571-04-1 | Details |
| CB1-IN-2 | C17H19Cl2N5O | 2527805-39-4 | Details |
| ATR-IN-19 | C18H19N7OS | 2648989-61-9 | Details |
| VEGFR-2-IN-23 | C22H15N5O2 | 2411174-53-1 | Details |
| Anti-inflammatory agent 8 | C18H15N5OS2 | 1103920-19-9 | Details |
| Nampt-IN-7 | C20H21N5O3 | 1223378-42-4 | Details |
| Antiparasitic agent-5 | C20H16ClN3O3 | 2494276-55-8 | Details |
| Anticancer agent 56 | C20H18ClN3O3 | 2241915-59-1 | Details |
| HDAC-IN-42 | C20H15NO7 | 2454024-18-9 | Details |
| ANO1-IN-2 | C16H14ClN3O2S2 | 637314-12-6 | Details |
| MMV687807 | C15H8ClF6NO2 | 1417658-11-7 | Details |
| GABAA receptor agent 5 | C21H25N3O2S | 1808389-92-5 | Details |
| BChE-IN-4 | C24H37N3O | 2304818-41-3 | Details |
| O-GlcNAcase-IN-4 | C16H22FN5O3S | 2241514-58-7 | Details |
| Tubulin polymerization-IN-10 | C18H21NO6S | 2238784-19-3 | Details |
| HIF-2α-IN-5 | C15H12F4O3S2 | 2388500-66-9 | Details |
| S1P1 agonist 4 | C24H31NO3 | 1883345-11-6 | Details |
| Falcipain-2/3-IN-2 | C21H23N3O4 | 946209-23-0 | Details |
| SARS-CoV-2-IN-17 | C19H19F3N2O3 | 2761911-44-6 | Details |
| Polyketide synthase 13-IN-2 | C22H21NO5 | 2219338-48-2 | Details |
| PKC-IN-4 | C21H25N5S | 2636771-29-2 | Details |
| ATR-IN-15 | C19H22N8O | 2756665-52-6 | Details |
| ERK5-IN-4 | C16H11Cl2FN4O2 | 1888305-17-6 | Details |
| Antibacterial agent 106 | C20H24N6S | 2459657-11-3 | Details |
| Anticancer agent 57 | C20H21Cl2NO2 | 2408017-71-8 | Details |
| ASK1-IN-3 | C18H18N8O2 | 2426705-19-1 | Details |
| TGFβ-IN-2 | C22H22N2O4 | 2387678-02-4 | Details |
| Autophagy inducer 3 | C24H43NO2 | 2691054-63-2 | Details |
| ATG7-IN-3 | C11H16N6O5S2 | 2226229-76-9 | Details |
| KDM5B-IN-3 | C19H25ClN4O2 | 1385101-10-9 | Details |
| HBV-IN-21 | C17H17FN4OS2 | 2460957-52-0 | Details |
| DMX-129 | C19H17FN8 | 1623123-95-4 | Details |
| HSV-1/HSV-2-IN-2 | C17H14ClFN4OS | 2490468-39-6 | Details |
| Trk-IN-20 | C22H18F2N4 | 2460924-63-2 | Details |
| Influenza A virus-IN-4 | C19H28N4O4 | 2390067-58-8 | Details |
| Mt KARI-IN-2 | C14H11N5O4S2 | 2413974-52-2 | Details |
| Aldose reductase-IN-6 | C20H16N4O2S | 2470019-41-9 | Details |
| CSF1R-IN-13 | C21H20N4O3 | 2361556-61-6 | Details |
| c-ABL-IN-3 | C17H11F3N4O3 | 2626934-64-1 | Details |
| GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
| ASIC-IN-1 | C23H25N3O2 | 308088-10-0 | Details |
| Tubulin polymerization-IN-13 | C20H21NO6 | 2426665-56-5 | Details |
| Antifungal agent 32 | C25H28N2O | 1809167-48-3 | Details |
| DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
| Antitubercular agent-24 | C18H19N3O2S2 | 1845719-43-8 | Details |
| A1AR antagonist 4 | C23H25N3O2 | 1031993-35-7 | Details |
| AAK1-IN-4 | C20H28N4O3 | 1815612-79-3 | Details |
| TP0480066 | C18H14FN3O5 | 2245693-15-4 | Details |
| 5-HT2A receptor agonist-2 | C20H21ClN2O3 | 528525-37-3 | Details |
| NHE3-IN-3 | C16H16Cl2N2O2S | 543734-50-5 | Details |
| Anti-inflammatory agent 22 | C22H16O6 | 2721484-76-8 | Details |
| NPR-C activator 1 | C18H24N6O3 | 2768328-61-4 | Details |
| PKM2 activator 3 | C15H11ClF2N2O3S | 1346113-84-5 | Details |
| Tubulin/HDAC-IN-1 | C21H18N4O3 | 2413587-26-3 | Details |
| ATG7-IN-2 | C11H16N6O7S | 2226227-75-2 | Details |
| 5-HT7 receptor ligand 1 | C21H23N7 | 2758571-64-9 | Details |
| S07-2010 | C19H21N3O3S | 1223194-71-5 | Details |
| FGFR-IN-7 | C16H21ClF2N4O2 | 2488764-17-4 | Details |
| S07-2005 (racemic) | C20H23NO6 | 1826337-40-9 | Details |
| EGFR-IN-51 | C21H15N3O2S | 2418549-32-1 | Details |
| NMDA receptor antagonist 5 | C19H16BrNO2 | 2415998-36-4 | Details |
| Antileishmanial agent-9 | C23H26O4 | 2477608-91-4 | Details |
| CXCR4 antagonist 5 | C21H30N6 | 2304749-86-6 | Details |
| (S)-Cdc7-IN-18 | C19H21N5OS | 2562329-13-7 | Details |
| NSC381467 | C20H16O7 | 1033006-96-0 | Details |
| PPARγ agonist 7 | C20H30O6 | 2569295-93-6 | Details |
| DPP-4 inhibitor 3 | C19H22N6O2 | 2402735-14-0 | Details |
| Gü1303 | C20H22N4O3 | 1043922-53-7 | Details |
| Tyrosinase-IN-3 | C21H23NO5 | 2409081-40-7 | Details |
| Cdc7-IN-18 | C19H21N5OS | 2562329-14-8 | Details |
| BuChE-IN-6 | C21H26N4O2 | 2003213-07-6 | Details |
| EV-A71-IN-1 | C21H15N5S | 2413648-96-9 | Details |
| PPARγ agonist 3 | C24H23N3O | 2011801-48-0 | Details |
| Anticancer agent 37 | C19H19N3O3S | 905783-28-0 | Details |
| ATR-IN-16 | C19H25N7O | 2756589-62-3 | Details |
| CXCR4 antagonist 6 | C21H30N6 | 2304750-68-1 | Details |
| HPK1-IN-18 | C24H24N4 | 2403598-42-3 | Details |
| TOPK-p38/JNK-IN-1 | C17H15F3N2O4 | 2745108-35-2 | Details |
| Tyrosinase-IN-5 | C18H13N3O6 | 2525175-90-8 | Details |
| DPP-4-IN-1 | C19H19ClN6 | 2215027-46-4 | Details |
| Product Total： Product Page： | ||||
| 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||